Royalty Pharma PLC (RPRX)
25.80
+0.10
(+0.37%)
USD |
NASDAQ |
Nov 18, 16:00
25.80
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Shareholders Equity (Quarterly): 6.870B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.870B |
| June 30, 2024 | 6.476B |
| March 31, 2024 | 6.500B |
| December 31, 2023 | 6.526B |
| September 30, 2023 | 6.139B |
| June 30, 2023 | 6.282B |
| March 31, 2023 | 5.954B |
| December 31, 2022 | 5.628B |
| September 30, 2022 | 6.152B |
| June 30, 2022 | 6.027B |
| Date | Value |
|---|---|
| March 31, 2022 | 5.778B |
| December 31, 2021 | 5.777B |
| September 30, 2021 | 5.793B |
| June 30, 2021 | 5.734B |
| March 31, 2021 | 4.882B |
| December 31, 2020 | 4.819B |
| September 30, 2020 | 4.452B |
| June 30, 2020 | 4.157B |
| March 31, 2020 | 5.160B |
| December 31, 2019 | 6.106B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.157B
Minimum
Jun 2020
6.870B
Maximum
Sep 2024
5.761B
Average
5.873B
Median
Shareholders Equity (Quarterly) Benchmarks
| Geron Corp | 292.28M |
| Amicus Therapeutics Inc | 178.82M |
| Ionis Pharmaceuticals Inc | 662.47M |
| Arbutus Biopharma Corp | 106.89M |
| Syndax Pharmaceuticals Inc | 366.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.04B |
| Total Liabilities (Quarterly) | 7.784B |
| Debt to Equity Ratio | 1.107 |
| Current Ratio | 1.536 |
| Net Debt Paydown Yield | -0.76% |